Many genes from the solute carrier (slc) family were also dysregulated, including downregulation of slc2a1a and slc9a5, as well as upregulation of slc23a3, slc27a2b, and slc26a3.2. These genes are implicated with hematological diseases or inflammatory responses. This evidence concerns the gene CCL21 and hematologic disorder.